Stromal COX-2 signaling are correlated with colorectal cancer: A review

被引:23
|
作者
Su, Chen-Wei [1 ]
Zhang, Yuan [2 ]
Zhu, Ying-Ting [1 ]
机构
[1] TissueTech Inc, Ocular Surface Ctr, Ocular Surface Res & Educ Fdn, R&D Dept, Miami, FL USA
[2] Dalian Cent Hosp, Dalian, Liaoning Provin, Peoples R China
关键词
Cyclooxygenase-2; Prostaglandin; Proliferation; Invasion; Colorectal; Cancer; NF-KAPPA-B; COLON-CARCINOMA CELLS; PROSTAGLANDIN E-2; CONSTITUTIVE EXPRESSION; PEROXISOME PROLIFERATOR; MEDIATES PROLIFERATION; SUBTYPE EP1; CYCLOOXYGENASE-2; GROWTH; ACTIVATION;
D O I
10.1016/j.critrevonc.2016.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclooxygenase-2 (COX-2) and its product prostaglandin E-2 (PGE(2)) play a critical role in development and progression of colorectal cancer. Yet the detailed mechanistic pathways of COX-2 mediated signaling are still controversial and the role of COX-2 interaction in epithelial-stromal compartments on colorectal carcinogenesis is not well-understood either. In this review, we provide experimental evidence to support that (1) COX-2 signaling plays a major role in development and progression of colorectal cancer; (2) Stromal fibroblasts are a major source of COX-2 and PGE2; (3) Stromal-epithelial interaction mediated by COX-2 signaling promotes colorectal carcinogenesis and (4) Inhibition of stromal COX-2 signaling is necessary to control colorectal cancer. In conclusion, the evidences summarized in the review reflect recent advances and insight in mechanistic studies of colorectal cancer which can help the audiences to further understand the etiology and the control of this disease. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [21] COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention
    Pereira, Carina
    Pimentel-Nunes, Pedro
    Brandao, Catarina
    Moreira-Dias, Luis
    Medeiros, Rui
    Dinis-Ribeiro, Mario
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (05) : 607 - 613
  • [22] Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer
    Cao, Chunxia
    Gao, Ruli
    Zhang, Min
    Amelio, Antonio L.
    Fallahi, Mohammad
    Chen, Zirong
    Gu, Yumei
    Hu, Chengbin
    Welsh, Eric A.
    Engel, Brienne E.
    Haura, Eric B.
    Cress, W. Douglas
    Wu, Lizi
    Zajac-Kaye, Maria
    Kaye, Frederic J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
  • [23] Functional Polymorphisms in COX-2 Gene Are Correlated with the Risk of Oral Cancer
    Li, Dong
    Hao, Shu-Hong
    Sun, Yan
    Hu, Chun-Mei
    Ma, Zhi-Hua
    Wang, Zhi Ming
    Liu, Jie
    Liu, Hong Bo
    Ye, Ming
    Zhang, Yu Fei
    Yang, Dong Sheng
    Shi, Guang
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [24] EpCAM and COX-2 expression are positively correlated in human breast cancer
    Gao, Shuhang
    Sun, Yan
    Liu, Xue
    Zhang, Dandan
    Yang, Xuesong
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 3755 - 3760
  • [25] COX-2 as a target for cancer chemotherapy
    Ghosh, Nilanjan
    Chaki, Rituparna
    Mandal, Vivekananda
    Mandal, Subhash C.
    PHARMACOLOGICAL REPORTS, 2010, 62 (02) : 233 - 244
  • [26] COX-2 Expression in Gastric Cancer
    Bekdemir, Handan
    Tekin, Salim B.
    Bilici, Mehmet
    Cayir, Kerim
    Gundogdu, Cemal
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (01): : 34 - 41
  • [27] Inhibition of TPPP3 attenuates β-catenin/NF-κB/COX-2 signaling in endometrial stromal cells and impairs decidualization
    Shukla, Vinay
    Kaushal, Jyoti Bala
    Sankhwar, Pushplata
    Manohar, Murli
    Dwivedi, Anila
    JOURNAL OF ENDOCRINOLOGY, 2019, 240 (03) : 417 - 429
  • [28] Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling
    Kim, Nayoung
    Kim, Chung Hyun
    Ahn, Dong-Won
    Lee, Kyoung Soo
    Cho, Soo-Jeong
    Park, Ji Hyun
    Lee, Mi Kyoung
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (03) : 480 - 487
  • [29] IS THERE A PLACE FOR PRACTICAL CHEMOPREVENTION OF COLORECTAL CANCER IN LIGHT OF COX-2 HETEROGENEITY?
    Lewitowicz, Piotr
    Koziel, Dorota
    Gluszek, Stanislaw Zbigniew
    Matykiewicz, Jaroslaw
    Wincewicz, Andrzej
    Horecka-Lewitowicz, Agata
    Nasierowska-Guttmejer, Anna
    POLISH JOURNAL OF PATHOLOGY, 2014, 65 (04) : 276 - 282
  • [30] Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer
    Patrignani, P
    TOXICOLOGY LETTERS, 2000, 112 : 493 - 498